Skip to main content
NTHI
NASDAQ Life Sciences

Investor Registers 555K Shares for Resale from April Private Placement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$4.88
Mkt Cap
$126.944M
52W Low
$3.2
52W High
$12.99
52W Position info
52% above low
Off High info
62% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

NTHI sits 52% above its 52-week low of $3.2.

Summary

A significant investor is registering over 555,000 shares for resale from a recent private placement, potentially adding selling pressure to NEONC Technologies, which will not receive proceeds from these sales.


Key Events · Financing and Capital Events · NTHI

  • Resale Registration

    A selling stockholder, 64K Capital, LLC, is registering 555,554 shares of common stock and warrants for resale. These shares were acquired in a private placement on April 20, 2026.

  • No Direct Proceeds to Company

    NEONC Technologies will not receive any proceeds from the sale of these shares by the selling stockholder. Proceeds would only come from the cash exercise of warrants, which are currently out-of-the-money (exercise price $9.00 vs. current stock price $4.88).

  • Potential Dilution

    The registered shares represent approximately 2.14% of the company's outstanding common stock, adding to potential market overhang.

  • Financial Context

    This potential selling pressure comes as the company continues to operate under a going concern warning and has recently engaged in multiple dilutive financing activities.


Analysis · NTHI · Life Sciences

This filing registers 555,554 shares and warrants for resale by a selling stockholder (64K Capital, LLC) who acquired them in a private placement on April 20, 2026. The company will not receive proceeds from the sale of these shares, only from the cash exercise of warrants, which are currently out-of-the-money. This adds potential selling pressure to a company already facing a going concern warning and recent dilutive financings.

At the time of this filing, NTHI was trading at $4.88 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $126.9M. The 52-week trading range was $3.20 to $12.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NTHI - Latest Insights

NTHI
Jul 15, 2026, 9:23 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.95
Real-time Price: $3.50 info
Change: -$0.450 (-11%) info
Market Cap: $90.762M info
NTHI
Jul 15, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.72
Real-time Price: $3.50 info
Change: -$0.220 (-6%) info
Market Cap: $90.762M info
NTHI
Jul 02, 2026, 5:11 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.42
Real-time Price: $3.50 info
Change: -$0.920 (-21%) info
Market Cap: $90.762M info
NTHI
Jun 23, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.88
Real-time Price: $3.50 info
Change: -$1.38 (-28%) info
Market Cap: $90.762M info
NTHI
Jun 23, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.35
Real-time Price: $3.50 info
Change: -$1.85 (-35%) info
Market Cap: $90.762M info